Yüklüyor......
Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
Immune checkpoint inhibitors (ICPis) have revolutionized cancer therapy with broad activities against a wide range of malignancies. However, in many malignancies their efficacy remains limited due to the primary resistance. Furthermore, a high percentage of patients develop progression due to the se...
Kaydedildi:
| Yayımlandı: | Med Sci (Basel) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6410194/ https://ncbi.nlm.nih.gov/pubmed/30678257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci7020014 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|